AIGH Capital Management »

Kempharm shares owned by AIGH Capital Management

Quarter-by-quarter ownership of Kempharm shares owned by AIGH Capital Management from 13F filings

Historical chart of AIGH Capital Management investment in Kempharm

Tip: Access up to 7 years of quarterly data

All positions including Kempharm held by AIGH Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kempharm by AIGH Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $9.0M 1.0M 8.96

More positions owned by AIGH Capital Management

Sandisk Corp (SNDK)
Zoom Communications Call Call Option
Castle Biosciences (CSTL)
Personalis Ord (PSNL)
Nlight (LASR)
Day One Biopharmaceuticals I (DAWN)
Vanda Pharmaceuticals (VNDA)
Bk Technologies Corporation Com New (BKTI)
Domo Com Cl B (DOMO)
Esperion Therapeutics (ESPR)
Kyverna Therapeutics (KYTX)
Fennec Pharmaceuticals (FENC)
Lightpath Technologies Com Cl A (LPTH)
Abeona Therapeutics Com New (ABEO)
Zevra Therapeutics Call Call Option

View all positions for AIGH Capital Management

Top funds holding Kempharm

AIGH Capital Management
Simplex Trading
Group One Trading

View all funds holding Kempharm